Breathe Well Live Well
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide; Drug: Formoterol
Sponsor: Intech Biopharm Ltd.
Completed – verified July 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
|
Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in …
Benzinga Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today shared positive results from an interim analysis of a pivotal Phase 2b study of dupilumab in adult patients with moderate-to-severe asthma, who are uncontrolled despite treatment with … |
View full post on asthma – Google News
|
Maxwell Biotech Venture Fund Invests in Pivotal Clinical Trial of Oxagen's …
Laser Focus world Maxwell Biotech Venture Fund (MBVF), founded with the help of Russian government-backed RVC, announced today that its investment committee approved the terms and the amount of an investment in Eleventa, a Russian biotech company, which was … |
View full post on asthma – Google News